| |
| |
|
| Insider
Information: |
Reynolds Francis |
| Relationship: |
10% Owner |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
9,045,920 |
|
|
Indirect Shares
|
23,488 |
|
|
| Direct
Value |
$3,602,809 |
|
|
|
Indirect Value
|
$9,355 |
|
|
| Total
Shares |
9,069,408 |
|
|
| Total
Value |
$3,612,164 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Invivo Therapeutics Holdings Cor... |
NVIV |
10% Owner |
2014-05-09 |
9,045,920 |
2014-05-09 |
23,488 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
360 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 7 of 15
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-07-09 |
4 |
AS |
$3.94 |
$47,280 |
D/D |
(12,000) |
12,963,020 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-07-10 |
4 |
AS |
$3.97 |
$47,640 |
D/D |
(12,000) |
12,951,020 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-07-11 |
4 |
AS |
$4.28 |
$51,360 |
D/D |
(12,000) |
12,939,020 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-07-12 |
4 |
AS |
$4.57 |
$54,840 |
D/D |
(12,000) |
12,927,020 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-07-15 |
4 |
AS |
$4.95 |
$59,400 |
D/D |
(12,000) |
12,915,020 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-07-16 |
4 |
AS |
$5.12 |
$61,440 |
D/D |
(12,000) |
12,903,020 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-07-17 |
4 |
AS |
$5.28 |
$63,360 |
D/D |
(12,000) |
12,891,020 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-07-18 |
4 |
AS |
$5.18 |
$62,160 |
D/D |
(12,000) |
12,879,020 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-07-19 |
4 |
AS |
$5.36 |
$64,320 |
D/D |
(12,000) |
12,867,020 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-07-22 |
4 |
AS |
$5.83 |
$69,960 |
D/D |
(12,000) |
12,855,020 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-07-23 |
4 |
AS |
$5.68 |
$68,160 |
D/D |
(12,000) |
12,843,020 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-07-24 |
4 |
AS |
$5.66 |
$67,920 |
D/D |
(12,000) |
12,831,020 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-07-25 |
4 |
AS |
$5.43 |
$65,160 |
D/D |
(12,000) |
12,819,020 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-07-26 |
4 |
AS |
$5.14 |
$61,680 |
D/D |
(12,000) |
12,807,020 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-07-29 |
4 |
AS |
$5.09 |
$61,080 |
D/D |
(12,000) |
12,795,020 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-07-30 |
4 |
AS |
$5.12 |
$61,440 |
D/D |
(12,000) |
12,783,020 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-08-01 |
4 |
AS |
$4.66 |
$55,920 |
D/D |
(12,000) |
12,771,020 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-08-02 |
4 |
AS |
$4.48 |
$53,760 |
D/D |
(12,000) |
12,759,020 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-08-05 |
4 |
AS |
$4.66 |
$55,920 |
D/D |
(12,000) |
12,747,020 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-08-06 |
4 |
AS |
$4.18 |
$50,160 |
D/D |
(12,000) |
12,735,020 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-08-07 |
4 |
AS |
$4.53 |
$54,360 |
D/D |
(12,000) |
12,723,020 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-08-08 |
4 |
AS |
$4.52 |
$54,240 |
D/D |
(12,000) |
12,711,020 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-08-09 |
4 |
AS |
$4.31 |
$51,720 |
D/D |
(12,000) |
12,699,020 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-08-12 |
4 |
AS |
$4.41 |
$52,920 |
D/D |
(12,000) |
12,687,020 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-08-13 |
4 |
AS |
$4.34 |
$52,080 |
D/D |
(12,000) |
12,675,020 |
0 |
- |
|
360 Records found
|
|
Page 7 of 15 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
